Facebook Linkedin Mail Twitter Youtube
  • Home
  • Research
  • Blog
  • TRIPS Flexibilities Database
  • Other Resources
    • Covid-19
    • Tools
      • Introduction
      • Model Government Use Licences
      • Model Uses of Paragraph 7 or “LDC Waiver”
      • Special Compulsory Licences for Export of Medicines
      • Options for Regional Economic Communities
      • Voluntary Licences
    • Useful Links
  • About
Search
Menu

Explore the website

Technical Briefing Papers

Deep dives into and analysis of issues that impact access to medicines.

Our Work on Covid-19

Our views on what governments and the international community can do to fight this pandemic and prepare for the next one.

Our Blog

Timely and topical analysis on the day-to-day issues in intellectual property and health.

The TRIPS Flexibilities Database

Instances when authorities have invoked, planned to/were asked to invoke a flexibility contained in the TRIPS Agreement for public health reasons.

Tools for Access to Medicines

Tools to help governments and others looking to increase access to medicines by using flexibilities in intellectual property law.

Meet the Team

Learn about Medicines Law & Policy's team of legal and policy experts.

Medicines Law & PolicyResearch and resources on intellectual property and health
Twitter
Linkedin
Facebook
Medicines Law & Policy
Research and resources
on intellectual property and health.
Contact Us
Subscribe

Subscribe to our newsletter and never miss a post!

* indicates required

Medicines Law & Policy will use the information you provide to keep you up-to-date when we post new research and insight. You can change your mind about receiving our newsletter any time by clicking the unsubscribe link in the footer of any email you receive from us. We will treat your information with respect. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Menu

Explore the website

Technical Briefing Papers

Deep dives into and analysis of issues that impact access to medicines.

Our Work on Covid-19

Our views on what governments and the international community can do to fight this pandemic and prepare for the next one.

Our Blog

Timely and topical analysis on the day-to-day issues in intellectual property and health.

The TRIPS Flexibilities Database

Instances when authorities have invoked, planned to/were asked to invoke a flexibility contained in the TRIPS Agreement for public health reasons.

Tools for Access to Medicines

Tools to help governments and others looking to increase access to medicines by using flexibilities in intellectual property law.

Meet the Team

Learn about Medicines Law & Policy's team of legal and policy experts.

  • Home
  • Research
  • Blog
  • TRIPS Flexibilities Database
  • Other Resources
    • Covid-19
    • Tools
      • Introduction
      • Model Government Use Licences
      • Model Uses of Paragraph 7 or “LDC Waiver”
      • Special Compulsory Licences for Export of Medicines
      • Options for Regional Economic Communities
      • Voluntary Licences
    • Useful Links
  • About

Ellen 't Hoen

63 POSTS 0 COMMENTS
http://medicineslawandpolicy.org
Ellen ‘t Hoen, LLM PhD, is a lawyer and public health advocate with over 30 years of experience working on pharmaceutical and intellectual property policies.

WTO Covid-19 TRIPS Decision: Some observations

Ellen 't Hoen - June 17, 2022

Wrapping up 2021 – some noteworthy medicines law and policy events

Ellen 't Hoen - December 24, 2021

Imagine if health and trade ministers would meet in one room this week

Ellen 't Hoen - November 30, 2021

The EU proposed Covid waivers of certain TRIPS rules are mostly meaningless

Ellen 't Hoen - October 14, 2021

Vaccine knowledge needs to be a global public good: Remarks to the World Trade...

Ellen 't Hoen - July 22, 2021

Covid shows the world it needs new rules to deal with pandemics

Ellen 't Hoen - May 21, 2021

Dutch Health Care Institute Says No to Medicines Pirate

Ellen 't Hoen - March 29, 2021

The European Commission says Covid-19 vaccines should be global public goods, but do their...

Ellen 't Hoen - January 28, 2021

The elephant in the room at the WHO Executive Board

Ellen 't Hoen - January 22, 2021

Some Surprises in the European Commission’s New Intellectual Property Strategy

Ellen 't Hoen - December 2, 2020
123...7Page 2 of 7

Medicines Law & Policy

Facebook
Linkedin
Twitter

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

  • Home
  • Research
  • Blog
  • TRIPS Flexibilities Database
  • Tools
  • Covid-19
  • Useful Links
  • About
  • TRIPS Flexibilities Database
  • Other resources

Never miss a post! Sign up for ML&P's mailing list by entering your information below. The list will only be used to inform you of new content (messages are sent approximately once a month).

* indicates required






Medicines Law & Policy will use the information you provide to keep you up-to-date when we post new research and insight. You can change your mind about receiving our newsletter any time by clicking the unsubscribe link in the footer of any email you receive from us. We will treat your information with respect. By clicking below, you agree that we may process your information in accordance with these terms. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

 
 

This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.